milrinone has been researched along with Pulmonary Arterial Hypertension in 1 studies
Pulmonary Arterial Hypertension: A progressive rare pulmonary disease characterized by high blood pressure in the PULMONARY ARTERY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nag, P | 1 |
| Chowdhury, SR | 1 |
| Behera, SK | 1 |
| Das, M | 1 |
| Narayan, P | 1 |
1 trial available for milrinone and Pulmonary Arterial Hypertension
| Article | Year |
|---|---|
Levosimendan or Milrinone for Ventricular Septal Defect Repair With Pulmonary Arterial Hypertension.
Topics: Cardiotonic Agents; Child; Heart Septal Defects, Ventricular; Heart Ventricles; Humans; Hydrazones; | 2023 |